Researchers at Stony Brook University in collaboration with colleagues at Johns Hopkins School of Medicine used DNA sequencing methods to make a new discovery: the direct causation of exposure to aristolochic acid (AA), which is found in a plant that’s been used in herbal remedies for thousands of years, in the development of urothelial cancer.
Clinical trials were recently conducted and proved promising for a Lyme Disease vaccine developed by science researchers at Stony Brook University. The vaccine proved to produce a large number of antibodies against all targeted species of Borrelia, which causes Lyme Disease in Europe and the United States. Baxter International S.A., who worked with Stony Brook University researchers to develop the vaccine, conducted the clinical trials.
After receiving $2 million in philanthropic gifts in honor of Thomas Hartman, the Thomas Hartman Center for Parkinson’s Research in the Stony Brook University Department of Neurobiology and Behavior was dedicated in a ceremony on June 13th, 2013. Thomas Hartman was a much loved priest, television and radio personality, and believer in many causes who was diagnosed with Parkinson’s disease in 2004.
Lab suppliers marketing university lab equipment and hoping to increase scientific product sales may want to take a closer look at Stony Brook University’s latest research funding grants. Stony Brook University was recently awarded $2.45 million from the New York state government to fund programs are that have been designated as having “high need.” The government will be awarding $12 million to 36 SUNY colleges over the next three years.